Friederike Holze
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Acute dose-dependent effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) compared with 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin in a double-blind, placebo-controlled study in healthy participants.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Published: February 11, 2026
The 3D-ASCr scale: A revalidation of the core dimensions of the Altered States of Consciousness Rating Scale 5D(11)-ASC for psychedelic research.
Journal: Journal of psychopharmacology (Oxford, England)
Published: December 26, 2025
Comparison of human metabolome changes identified in a placebo-controlled amphetamine administration study versus those using forensic toxicology routine data.
Journal: Scientific reports
Published: June 20, 2025
Integrating the Mystical Experience Questionnaire Into a Broader Psychometric Framework: English Validation of the Psychedelic Experience Scale and Comparison of Psilocybin and LSD Sessions Across Two Controlled Settings.
Journal: International journal of methods in psychiatric research
Published: June 09, 2025
A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.
Journal: Psychedelic medicine (New Rochelle, N.Y.)
Published: May 12, 2025
Absolute Oral Bioavailability and Bioequivalence of LSD Base and Tartrate in a Double-Blind, Placebo-Controlled, Crossover Study.
Journal: Clinical pharmacology and therapeutics
Published: February 27, 2025
Liquid chromatography-tandem mass spectrometry-based pharmacokinetic and metabolic analysis of 4-bromo-2,5-dimethoxyphenethylamine and its metabolites in human plasma.
Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: February 12, 2025
Oxytocin and the Role of Fluid Restriction in MDMA-Induced Hyponatremia: A Secondary Analysis of 4 Randomized Clinical Trials.
Journal: JAMA network open
Published: November 15, 2024
Treatment of neuropathic pain with repeated low-dose MDMA: a case report.
Journal: Frontiers in psychiatry
Published: October 17, 2024
Naturalistic psychedelic therapy: The role of relaxation and subjective drug effects in antidepressant response.
Journal: Journal of psychopharmacology (Oxford, England)
Published: September 20, 2024
LSD-assisted therapy in patients with anxiety: open-label prospective 12-month follow-up.
Journal: The British journal of psychiatry : the journal of mental science
Published: July 30, 2024
Pharmacological Properties of Psychedelics with a Special Focus on Potential Harms.
Journal: Current topics in behavioral neurosciences
Published: July 30, 2024
Last Updated: 09/26/2026